JENNIFER CAIN: Open Payments
NPI 1174168942 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 63 payments from 15 companies in 2025. Trend: 2023 $1,180 · 2024 $970 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $292 |
| Lilly USA, LLC | 16 | $196 |
| Novo Nordisk Inc | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 1 | $49 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $37 |
| PFIZER INC. | 2 | $31 |
| Radius Health, Inc. | 1 | $28 |
Products named: UBRELVY, MOUNJARO, QULIPTA, JARDIANCE, Wegovy, REXULTI, GEMTESA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
